Cargando…
Discovery of C19-9 as a novel non-RGD inhibitor of αvβ3 to overcome enzalutamide resistance in castration-resistant prostate cancer
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911763/ https://www.ncbi.nlm.nih.gov/pubmed/36759595 http://dx.doi.org/10.1038/s41392-022-01236-z |
_version_ | 1784885060441210880 |
---|---|
author | Pang, Xiaocong Sun, Xiaojiao Gu, Yanlun He, Xu Gong, Kan Song, Song Zhang, Jixin Xia, Jie Liu, Zhenming Cui, Yimin |
author_facet | Pang, Xiaocong Sun, Xiaojiao Gu, Yanlun He, Xu Gong, Kan Song, Song Zhang, Jixin Xia, Jie Liu, Zhenming Cui, Yimin |
author_sort | Pang, Xiaocong |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9911763 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-99117632023-02-11 Discovery of C19-9 as a novel non-RGD inhibitor of αvβ3 to overcome enzalutamide resistance in castration-resistant prostate cancer Pang, Xiaocong Sun, Xiaojiao Gu, Yanlun He, Xu Gong, Kan Song, Song Zhang, Jixin Xia, Jie Liu, Zhenming Cui, Yimin Signal Transduct Target Ther Letter Nature Publishing Group UK 2023-02-10 /pmc/articles/PMC9911763/ /pubmed/36759595 http://dx.doi.org/10.1038/s41392-022-01236-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Letter Pang, Xiaocong Sun, Xiaojiao Gu, Yanlun He, Xu Gong, Kan Song, Song Zhang, Jixin Xia, Jie Liu, Zhenming Cui, Yimin Discovery of C19-9 as a novel non-RGD inhibitor of αvβ3 to overcome enzalutamide resistance in castration-resistant prostate cancer |
title | Discovery of C19-9 as a novel non-RGD inhibitor of αvβ3 to overcome enzalutamide resistance in castration-resistant prostate cancer |
title_full | Discovery of C19-9 as a novel non-RGD inhibitor of αvβ3 to overcome enzalutamide resistance in castration-resistant prostate cancer |
title_fullStr | Discovery of C19-9 as a novel non-RGD inhibitor of αvβ3 to overcome enzalutamide resistance in castration-resistant prostate cancer |
title_full_unstemmed | Discovery of C19-9 as a novel non-RGD inhibitor of αvβ3 to overcome enzalutamide resistance in castration-resistant prostate cancer |
title_short | Discovery of C19-9 as a novel non-RGD inhibitor of αvβ3 to overcome enzalutamide resistance in castration-resistant prostate cancer |
title_sort | discovery of c19-9 as a novel non-rgd inhibitor of αvβ3 to overcome enzalutamide resistance in castration-resistant prostate cancer |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911763/ https://www.ncbi.nlm.nih.gov/pubmed/36759595 http://dx.doi.org/10.1038/s41392-022-01236-z |
work_keys_str_mv | AT pangxiaocong discoveryofc199asanovelnonrgdinhibitorofavb3toovercomeenzalutamideresistanceincastrationresistantprostatecancer AT sunxiaojiao discoveryofc199asanovelnonrgdinhibitorofavb3toovercomeenzalutamideresistanceincastrationresistantprostatecancer AT guyanlun discoveryofc199asanovelnonrgdinhibitorofavb3toovercomeenzalutamideresistanceincastrationresistantprostatecancer AT hexu discoveryofc199asanovelnonrgdinhibitorofavb3toovercomeenzalutamideresistanceincastrationresistantprostatecancer AT gongkan discoveryofc199asanovelnonrgdinhibitorofavb3toovercomeenzalutamideresistanceincastrationresistantprostatecancer AT songsong discoveryofc199asanovelnonrgdinhibitorofavb3toovercomeenzalutamideresistanceincastrationresistantprostatecancer AT zhangjixin discoveryofc199asanovelnonrgdinhibitorofavb3toovercomeenzalutamideresistanceincastrationresistantprostatecancer AT xiajie discoveryofc199asanovelnonrgdinhibitorofavb3toovercomeenzalutamideresistanceincastrationresistantprostatecancer AT liuzhenming discoveryofc199asanovelnonrgdinhibitorofavb3toovercomeenzalutamideresistanceincastrationresistantprostatecancer AT cuiyimin discoveryofc199asanovelnonrgdinhibitorofavb3toovercomeenzalutamideresistanceincastrationresistantprostatecancer |